Alustraße 50 - 52
92421 Schwandorf, de
+49 (9431) 53-202
Nabaltec AG: Shareholders adopt a dividend of EUR 0.15 per share at the 2016 Annual Meeting and approve all agenda items with a large majority
In light of the successful 2015 Financial Year, the shareholders approved the joint recommendation from the Management and Supervisory Boards with regard to the appropriation of earnings by a large majority. Accordingly, the shareholders voted to raise the dividend from EUR 0.12 to EUR 0.15 per share, to be paid out on 1 July 2016. The residual retained profit, in the amount of EUR 5,453,903.55, will be carried forward to new account, ensuring that additional capital will be available to the company to support its policy of sustained growth.
In addition to approving the actions of the Management and Supervisory Boards and electing an auditor for 2016, the shareholders also approved revisions to authorized capital, to the authorization for the issuance of warrants and/or convertible bonds, including changes to the relevant amounts, to conditional capital and to the five-year authorization for the conduct of a share buyback program.
"We are pleased by the broad support for our resolutions from our shareholders, which represents yet another affirmation of our corporate strategy," said Gerhard Witzany, Member of the Board of Nabaltec AG. "We are currently in a volatile market environment and must retain the ability to act flexibly. Our innovative products allow us to do so in our markets, to a large extent, as demonstrated by our results for the year 2015 and the first quarter of 2016. On the financing side as well, we continue to be optimally positioned for the future."
Note: The voting results at Nabaltec AG's 2016 Annual Meeting will be available for download as of 1 July 2016 in the Investor Relations section of www.nabaltec.de.
The use of information published here for personal information and editorial processing is generally free of charge. Please clarify any copyright issues with the stated publisher before further use. In the event of publication, please send a specimen copy to firstname.lastname@example.org.